期刊
CELL DEATH AND DIFFERENTIATION
卷 13, 期 4, 页码 539-550出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.cdd.4401769
关键词
HATs; HDACs; neurodegeneration; acetylation homeostasis
资金
- NIA NIH HHS [AG19487] Funding Source: Medline
- NINDS NIH HHS [R01 NS039940, NS39940, R21 NS048923, R21 NS048923-01A2, R01 NS039940-06] Funding Source: Medline
Gradual disclosure of the molecular basis of selective neuronal apoptosis during neurodegenerative diseases reveals active participation of acetylating and deacetylating agents during the process. Several studies have now successfully manipulated neuronal vulnerability by influencing the dose and enzymatic activity of histone acetyltransferases (HATs) and histone deacetylases (HDACs), enzymes regulating acetylation homeostasis within the nucleus, thus focusing on the importance of balanced acetylation status in neuronal vitality. It is now increasingly becoming clear that acetylation balance is greatly impaired during neurodegenerative conditions. Herein, we attempt to illuminate molecular means by which such impairment is manifested and how the compromised acetylation homeostasis is intimately coupled to neurodegeneration. Finally, we discuss the therapeutic potential of reinstating the HAT-HDAC balance to ameliorate neurodegenerative diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据